Germany licenses Oralair for children's grass allergies
This article was originally published in Scrip
Executive Summary
Germany's Paul-Ehrlich Institute has granted a paediatric marketing authorisation for Stallergenes' Oralair Grasses sublingual tablet therapy for desensitisation to grass pollens in children five to 17 years old. It was licensed for adult use in Germany in June last year, and Germany is acting as the reference member state in the EU's mutual recognition procedure for both the adult and child indications.